MedTrace Logo

Effects of Antiviral Therapy on Patients With HBV-related HCC

NCT05406089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 494

Last updated 2022-06-21

No results posted yet for this study

Summary

Based on the follow-up data of patients who underwent hepatectomy for HBV-related HCC at the First Affiliated Hospital of Xi'an Jiaotong University. patients who met the enrollment criteria were screened for tumor recurrence and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

Conditions

Interventions

OTHER

Medication history

The study was retrospective and did not involve the application of interventions

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Bo Wang, MD PhD · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2019-06-30
Completion
2019-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406089 on ClinicalTrials.gov